Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05090722 · ClinicalTrials.gov registry record · NA
A Pilot Study to Evaluate PureWick for Nocturia
A NA study, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05090722 is a NA study that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 40 participants.
The verdict
NCT05090722, a NA study, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a single-center prospective pilot study of PureWick used as a management for nocturia and reduction of nighttime falls associated with going to the bathroom. Subjects are followed up to 3 months after the intervention. As a pilot study, it is expected that a 3-month follow-up will adequately capture urinary and sleep outcomes data and any adverse events related or unrelated to the study device.
Interventions
- DEVICE PureWick System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-12-16 |
| Est. Completion | 2027-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05090722
The ClinicalTrials.gov registry entry for NCT05090722 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PureWick System is the first listed.
NCT05090722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05090722 about?
NCT05090722 is a clinical study titled "A Pilot Study to Evaluate PureWick for Nocturia". This is a single-center prospective pilot study of PureWick used as a management for nocturia and reduction of nighttime falls associated with going to the bathroom. Subjects are followed up to 3 months after the intervention. As a pilot study, it is expected that a 3-month follow-up will adequately...
What is the current status of trial NCT05090722?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-12-16. Estimated completion is 2027-10.
What interventions are being tested in trial NCT05090722?
The interventions under investigation include: PureWick System (DEVICE).
Who is sponsoring clinical trial NCT05090722?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.